Print Page | Contact Us | Report Abuse | Sign In | Join/Renew
Invitation to Join the Compendium
Share |

On behalf of the Board of Directors and leadership of the American Society for Experimental Neurotherapeutics (ASENT), I am pleased to invite you to participate in the COMPENDIUM OF EMERGING COMPANIES IN NEUROTHERAPEUTICS.

ASENT is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders.  This new initiative is a compilation of companies (<40 FT employees) engaged in developing and commercializing therapies for central nervous system disorders.

The COMPENDIUM will be a gateway for discussion with scientists, investors, businesses, and venture capital. Participation in the COMPENDIUM will include the following:

  • One page in the annual printed COMPENDIUM distributed to attendees at the ASENT Annual Meeting. The next ASENT Annual Meeting is scheduled for March 25-28, 2019 at the Marriott Bethesda North Hotel and Conference Center.
  • Featured on the ASENT website through March 2019.
  • Listed once annually—with contact information only—in the journal Neurotherapeutics

The requirements:  The company must be active in either producing a neurologic-related product (device, drug, or other) or be active in investigation of such a neurologic product.

The rules: Each company will produce a SINGLE PAGE describing the company, the product, and current research progress, if appropriate. A logo is permitted.  Please see the attached example of Marinus Pharmaceuticals, Inc.

The cost: $1,000/year. 

To participateOnline Submission (preferred method)

You will be asked to submit your logo (high res jpg or png), one page summary and payment.

 Pay via credit card or check: Checks should made payable to “ASENT” and mailed to

ASENT
230 Kings Highway East, Ste #245
Haddonfield, NJ 08033.

Enclose your check with your one-page summary. Please also email your contact information, logo (high res jpg or png) and one page summary to jessicasmith.asent@gmail.com

This COMPENDIUM is a new way to get your company closer to the key stakeholders who need to hear about your product and/or your research. Thank you for your consideration. We look forward to learning more about your company.

Best Wishes

Thomas Sutula, MD, PhD
University of Wisconsin, Madison
President, ASENT

American Society for Experimental Neurotherapeutics
230 Kings Highway East, Ste 245
Haddonfield, NJ 08033
p: 833.273.6800
e: jessicasmith.asent@gmail.com

   Connect with Us